UNMNYSEAccident & Health InsuranceFiscal year ends December 31Also trades as UNMA
Unum Group
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$91.77−0.46 (-0.50%)
Close on Oct 19, 2026
- Market cap
- $14.69B
- P/E (TTM)
- 21.4
- Dividend yield
- 1.92%
Margins
Share of revenue, fiscal years 2011 to 2025
Operating margin
–
Net margin
5.6%−0.4 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +1.5% | +2.9% | -0.1% | +2.0% | |
| Net income | -58.5% | -19.3% | -1.4% | -1.6% | |
| EPS, diluted | -54.9% | -15.0% | +1.9% | +2.0% | |
| Free cash flow | -60.0% | -25.0% | +9.7% | -7.4% | |
| Dividend per share | +12.1% | +11.8% | +9.1% | – |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 10.6% | 7.6% | 6.7% | |
| Return on assets | 1.5% | 1.2% | 1.2% | |
| Debt to equity | 0.33 | 0.31 | 0.34 | |
| Capex to revenue | 0.8% | 0.9% | 1.0% | |
| Diluted shares | 236M | 204M | 173M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Unum generated $6.21B from operations and spent $4.46B on capital expenditure, dividends and share buybacks. 14% of that went back into the business.
Generated
$6.21B
Used
$4.46B
Capital expenditure$605.30M14%Dividends$1.37B31%Share buybacks$2.48B56%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin5.6%
×Asset turnover0.21×
×Equity multiplier5.68×
=Return on equity, FY20256.7%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 5.6% | 0.21× | 5.68× | 6.7% |
| FY2024 | 13.8% | 0.21× | 6.07× | 17.3% |
| FY2023 | 10.4% | 0.20× | 6.77× | 14.0% |
| FY2022 | 11.7% | 0.18× | 8.89× | 19.1% |
| FY2021 | 8.2% | 0.17× | 8.33× | 11.6% |
| FY2020 | 6.0% | 0.19× | 6.61× | 7.6% |
| FY2019 | 9.2% | 0.19× | 6.93× | 11.8% |
| FY2018 | 4.5% | 0.18× | 6.92× | 5.8% |
| FY2017 | 8.8% | 0.18× | 6.79× | 10.7% |
| FY2016 | 8.4% | 0.18× | 6.95× | 10.6% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
4of 7 tests passed in fiscal 2025. Some tests lack the figures they need.
- ProfitableNet income above zero$738.50M
- Cash generatingOperating cash flow above zero$687.70M
- Return on assets improvedROA up on the prior year2.8% → 1.2%
- Earnings backed by cashOperating cash flow above net income$687.70M vs $738.50M
- Less leverageLong-term debt to assets fell5.6% → 5.9%
- Better liquidityCurrent ratio rose– → –
- No dilutionShare count did not rise188M → 173M
- Gross margin improvedGross margin up on the prior year– → –
- More efficientAsset turnover rose0.20 → 0.21